Literature DB >> 15166534

Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection.

Kimberly C Brouwer1, Renu B Lal, Lisa B Mirel, Chunfu Yang, Anne M van Eijk, John Ayisi, Juliana Otieno, Bernard L Nahlen, Richard Steketee, Altaf A Lal, Ya Ping Shi.   

Abstract

OBJECTIVE: To evaluate the effect of polymorphism of the Fc gamma receptor IIa, which is associated with differential human IgG subclass binding, on perinatal HIV-1 transmission.
METHODS: Fc gamma RIIa genotype was tested in 448 HIV-seropositive mothers and their infants from a cohort study designed to assess the effect of placental malaria on HIV vertical transmission conducted from 1996 to 2001 in western Kenya. Fc gamma RIIa polymorphism was analyzed for associations with susceptibility to perinatal HIV infection and all-cause child mortality in HIV-positive children.
RESULTS: Overall, 20% of infants were perinatally infected with HIV. There was no statistically significant association between maternal genotype and perinatal HIV-1 transmission. However, frequency of the infant Fc gamma RIIa His/His131 genotype was higher in HIV-positive compared with HIV-negative infants (35% and 21%, respectively), whereas the distribution was reversed (15% and 28%, respectively) for infants with the Fc gamma RIIa Arg/Arg131 genotype. Multivariate logistic regression controlling for maternal and infant confounding factors demonstrated that the odds of perinatal HIV infection in infants with the Fc gamma RIIa His/His131 versus Fc gamma RIIa His/Arg131 genotypes were significantly higher (adjusted odds ratio, 2.22; 95% confidence interval, 1.23-4.02; P = 0.009). There was no evidence for an association between HIV-positive child all-cause mortality and Fc gamma RIIa genotype.
CONCLUSIONS: This study provides the first evidence that the infant Fc gamma RIIa His/His131 genotype is associated with susceptibility to perinatal HIV-1 transmission and further suggests that there is a dose-response relationship for the effect of the Fc gamma RIIa His131 gene on transmission.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166534     DOI: 10.1097/00002030-200405210-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  33 in total

Review 1.  The Antibody Response against HIV-1.

Authors:  Julie Overbaugh; Lynn Morris
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  Enhanced in vitro transcytosis of simian immunodeficiency virus mediated by vaccine-induced antibody predicts transmitted/founder strain number after rectal challenge.

Authors:  Sandeep Gupta; Poonam Pegu; David J Venzon; Johannes S Gach; Zhong-Min Ma; Gary Landucci; Christopher J Miller; Genoveffa Franchini; Donald N Forthal
Journal:  J Infect Dis       Date:  2014-05-21       Impact factor: 5.226

3.  Short communication: Fc gamma receptors IIa and IIIa genetic polymorphisms do not predict HIV-1 disease progression in Kenyan women.

Authors:  Julie F Weis; R Scott McClelland; Walter Jaoko; Kishor N Mandaliya; Julie Overbaugh; Susan M Graham
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-13       Impact factor: 2.205

4.  Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcγR2a and FcγR2b.

Authors:  Margaret E Ackerman; Anne-Sophie Dugast; Elizabeth G McAndrew; Stephen Tsoukas; Anna F Licht; Darrell J Irvine; Galit Alter
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

Review 5.  The role of Fc receptors in HIV infection and vaccine efficacy.

Authors:  Sarah L Cocklin; Joern E Schmitz
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

6.  Epistatic interactions between Fc (GM) and FcγR genes and the host control of human immunodeficiency virus replication.

Authors:  Raymond N Deepe; Emily Kistner-Griffin; Jeffrey N Martin; Steven G Deeks; Janardan P Pandey
Journal:  Hum Immunol       Date:  2011-12-11       Impact factor: 2.850

Review 7.  Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Authors:  Margaret E Ackerman; Galit Alter
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

8.  Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.

Authors:  Diego A Vargas-Inchaustegui; Marjorie Robert-Guroff
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

9.  Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses.

Authors:  Halina M Trist; Peck Szee Tan; Bruce D Wines; Paul A Ramsland; Eva Orlowski; Janine Stubbs; Elizabeth E Gardiner; Geoffrey A Pietersz; Stephen J Kent; Ivan Stratov; Dennis R Burton; P Mark Hogarth
Journal:  J Immunol       Date:  2013-12-16       Impact factor: 5.422

Review 10.  The role of Fc receptors in HIV prevention and therapy.

Authors:  Austin W Boesch; Eric P Brown; Margaret E Ackerman
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.